Procter & Gamble shares rise: Organic sales are stalling

Sales should recover in the next six months, said CFO Andre Schulten on Thursday when presenting business figures. The last quarter had difficult comparisons because consumers in the USA had stocked up on essential goods and detergents in the same period last year due to a port strike. The partial shutdown of the US government and the temporary suspension of food aid also had a negative impact. Procter & Gamble confirmed the forecast for the 2025/26 financial year, which runs until the end of June.

Investors echoed management’s optimism. The share price recently increased by 2.6 percent.

P&G barely grew in the second quarter due to weak demand. A slight organic increase in the cosmetics and health care sectors was offset by weak demand for baby care, feminine hygiene and household goods products.

In the three months to the end of December, revenue rose by one percent to 22.2 billion US dollars (around 19 billion euros). Adjusted for exchange rate and portfolio effects, growth even stagnated. Analysts, however, had expected a small increase. The bottom line is that the consumer goods company earned $4.3 billion in the quarter, seven percent less than in the same period last year. At $1.88, earnings per share (EPS) adjusted for special factors were at the previous year’s level and therefore slightly above analysts’ expectations.

In NYSE trading, P&C shares temporarily traded 2.97 percent higher at $150.40.

/err/mis

CINCINNATI (dpa-AFX)

Selected leverage products on Procter Gamble

With knock-outs, speculative investors can participate disproportionately in price movements. Simply select the leverage you want and we will show you suitable open-end products on Procter Gamble

The leverage must be between 2 and 20

Advertising